AFC
WST icon

Ares Financial Consulting’s West Pharmaceutical WST Stock Holding History

Ares Financial Consulting’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.5K Buy
163
+10
+7% +$3.06K 0.04% 204
2026
Q1 		$38.7K Buy
153
+147
+2,450% +$36.6K 0.03% 254
2025
Q4 		$1.65K Buy
+6
New +$1.64K ﹤0.01% 689

Other funds holding WST

TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Ares Financial Consulting's WST Position: Q2 2026 in Review

Ares Financial Consulting increased its West Pharmaceutical (WST) stake by 6.5% in Q2 2026, buying an estimated $3.06K and bringing the position to 163 shares worth $58.5K. The position accounts for 0.04% of the portfolio, ranked #204.

Ares Financial Consulting first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 366 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Ares Financial Consulting held 163 shares of West Pharmaceutical worth $58.5K as of Q2 2026.
  • Ares Financial Consulting bought 10 West Pharmaceutical shares in Q2 2026, an estimated $3.06K.
  • West Pharmaceutical made up 0.04% of Ares Financial Consulting's portfolio in Q2 2026, its #204 holding.
  • Ares Financial Consulting first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 366 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.